Codexis (CDXS) Cost of Revenue (2010 - 2026)
Codexis' (CDXS) quarterly Cost of Revenue came in at $2.1 million in Q1 2026, down 24.45% year-on-year from $2.7 million in Q1 2025, and up 1.03% quarter-over-quarter from $2.0 million in Q4 2025.
Codexis (CDXS) Cost of Revenue (2010 - 2026) Analysis & Trends
Codexis' Cost of Revenue history runs 17 years deep, the most recent figure standing at $2.1 million for Q1 2026.
- On a quarterly basis, Cost of Revenue fell 24.45% year-over-year to $2.1 million in Q1 2026; TTM through Mar 2026 was $8.7 million, a 38.79% decrease from a year earlier, with the FY2025 full-year figure at $9.3 million, down 42.67% from the prior year.
- Cost of Revenue climbed to $2.1 million in Q1 2026 per CDXS's latest filing, from $2.0 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $11.3 million in Q2 2022 and bottomed at $2.0 million in Q4 2025.
- The 5-year median for Cost of Revenue is $3.5 million (2024), against an average of $4.6 million.
- Across the five-year window, Cost of Revenue jumped 161.0% in 2022 and sank 77.02% in 2023, its largest moves.
- Year by year, Cost of Revenue stood at $8.5 million in 2022, then plunged by 66.15% to $2.9 million in 2023, then increased by 27.67% to $3.7 million in 2024, then sank by 44.09% to $2.0 million in 2025, then grew by 1.03% to $2.1 million in 2026.
- Per Business Quant, the three latest CDXS Cost of Revenue figures stand at $2.1 million (Q1 2026), $2.0 million (Q4 2025), and $2.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 167.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 392.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 296.00 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 145.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Codexis | 135.70 Mn | 70.56 Mn | 13.18 Mn | 2.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.06 Mn |
| Mar 31, 2026 | 2.06 Mn |
| Dec 31, 2025 | 2.04 Mn |
| Dec 31, 2025 | 2.04 Mn |
| Sep 30, 2025 | 2.47 Mn |
| Sep 30, 2025 | 2.47 Mn |
| Jun 30, 2025 | 2.10 Mn |
| Jun 30, 2025 | 2.10 Mn |
| Mar 31, 2025 | 2.73 Mn |
| Mar 31, 2025 | 2.73 Mn |
| Dec 31, 2024 | 3.65 Mn |
| Dec 31, 2024 | 3.65 Mn |
| Sep 30, 2024 | 4.32 Mn |
| Sep 30, 2024 | 4.32 Mn |
| Jun 30, 2024 | 3.46 Mn |
| Jun 30, 2024 | 3.46 Mn |
| Mar 31, 2024 | 4.86 Mn |
| Mar 31, 2024 | 4.86 Mn |
| Dec 31, 2023 | 2.86 Mn |
| Dec 31, 2023 | 2.86 Mn |